Clinical Trial Update: PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating palbociclib combined with tamoxifen for HR-positive, HER2-negative advanced breast cancer in Asian women is reported as an update wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: National Cancer Center, Japan | Conditions: Breast Neoplasms | Phase 3 | Status: UNKNOWN